Loading Events

« All Events

Pulmonary-Allergy Drugs Advisory Committee

May 8

The committee will discuss new drug application (NDA) 202049,for mannitol inhalation powder, for oral inhalation submittedby ChiesiUSA,Inc.,for the proposed indication of management of cystic fibrosis to improve pulmonary function in patients 18 years of age and older in conjunction with standard therapy.

Details

Date:
May 8
Event Category: